AzTrials
AzTrials

Type 2 Diabetes Mellitus (T2DM)MindfulT2DCANCT07617766

Mindfulness Training in Type 2 Diabetes

A study testing Mindfulness-Based Self-Management Education in people with Type 2 Diabetes Mellitus (T2DM), run by Ataturk University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to evaluate the effects of mindfulness-based self-management education on diabetes-related difficulties and empowerment in individuals with type 2 diabetes. Participants will receive a structured education program designed to improve self-care behaviors, emotional well-being, and confidence in managing… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Type 2 Diabetes Mellitus (T2DM)
What is being tested?
Mindfulness-Based Self-Management Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteTurkey (Türkiye)
Study dates
May 2026to May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged between 18 and 65 years.
  • Diagnosed with Type 2 diabetes mellitus.
  • Literate (able to read and write).
  • Has access to and is able to actively use a smartphone or internet.
  • No diagnosed mental or cognitive impairment.
  • Willing to participate voluntarily and provide informed consent.

Who cannot join

  • Previously received structured education related to their diabetes.
  • Pregnant.
  • Currently participating in another research study.
  • Hospitalized due to diabetes-related complications.
  • Unable to complete the education program.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Esmanur Günal, MSc contact

+905537066125

esmanurgunal2001@gmail.com

Turkey (Türkiye)1 site
  • Tortum State Hospital

    Erzurum, Tortum, 25430

    Esmanur Günal, MSc, +905537066125, esmanurgunal2001@gmail.com

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Mindfulness-Based Self-Management Education on Diabetes-Related Difficulties and Empowerment in Individuals With Type 2 Diabetes

This study aims to evaluate the effects of mindfulness-based self-management education on diabetes-related difficulties and empowerment in individuals with type 2 diabetes. Participants will receive a structured education program designed to improve self-care behaviors, emotional well-being, and confidence in managing their condition.

The program includes mindfulness practices, diabetes self-management education, and supportive group sessions. Outcomes such as diabetes distress, self-management behaviors, and patient empowerment will be measured before and after the intervention.

The findings of this study are expected to contribute to improving patient-centered care and supporting individuals with type 2 diabetes in managing their health more effectively.

Read the detailed description

Type 2 diabetes is a chronic condition that requires continuous self-management, including medication adherence, lifestyle modification, and emotional coping. Many individuals experience diabetes-related difficulties, reduced motivation, and challenges in maintaining long-term self-care behaviors. Mindfulness-based approaches have been shown to improve emotional regulation, stress management, and self-efficacy in individuals with chronic illnesses.

This study is designed as a randomized controlled trial to evaluate the effectiveness of a mindfulness-based self-management education program in individuals with type 2 diabetes. Participants will be randomly assigned to either an intervention group or a control group. The intervention group will receive a structured program consisting of mindfulness practices, diabetes education, and group-based support sessions. The control group will receive usual care.

Primary outcomes include diabetes-related difficulties and patient empowerment. Secondary outcomes include self-care behaviors, emotional well-being, and perceived quality of life. Data will be collected at baseline and after completion of the intervention using validated assessment tools.

This study aims to provide evidence on whether integrating mindfulness into diabetes self-management education can improve both psychological and behavioral outcomes, thereby enhancing overall diabetes care and patient well-being.

Being tested
Mindfulness-Based Self-Management Education, Usual Care
Keywords
Mindfulness, Type 2 diabetes, Self-management education, Patient empowerment, Behavioral intervention, Diabetes difficulties
Medical subject headings
Diabetes Mellitus, Type 2, Patient Participation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mindfulness-Based Self-Management EducationBehavioural

    A structured education program including mindfulness practices, diabetes self-management education, and group-based support sessions

  • Usual CareBehavioural

    Also called Standard diabetes care as provided by the healthcare system.

    Usual Care Control Group

Study groups in NCT07617766
Study groupRoleWhat they receive
Mindfulness-Based Self-Management Education GroupExperimentalParticipants will receive a structured mindfulness-based self-management education program in addition to usual care.
Receives: Behavioral: Mindfulness-Based Self-Management Education
Usual Care Control GroupActive comparatorParticipants will receive standard diabetes care without additional intervention.
Receives: Behavioral: Usual Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in self-management behavior score

    Measured using a validated self-management questionnaire

    Measured: Baseline to 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jun 2026
  2. Study startMay 2026 (estimated)
  3. Primary completionSep 2026 (estimated)
  4. Study completionMay 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned to either a mindfulness-based self-management education group or a usual care control group.
Masking
None (open label)
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07617766
Sponsor's protocol ID
AtaturkUnurse
Acronym
MindfulT2DCA
Status last verified
May 2026
First submitted
11 Feb 2026
Last updated
1 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared due to confidentiality considerations and institutional data protection policies.

Questions about this trial

What is this clinical trial studying?

A study testing Mindfulness-Based Self-Management Education in people with Type 2 Diabetes Mellitus (T2DM), run by Ataturk University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 1 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Esmanur Günal, MSc (+905537066125, esmanurgunal2001@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in self-management behavior score (time frame: Baseline to 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Mindfulness Training in Type 2 Diabetes (NCT07617766) | AzTrials